[Non-Hodgkin's lymphoma of the stomach, surgical therapy and prognosis].
In a retrospective study, clinical and histopathologic factors of 41 patients with a primary gastric non-Hodgkin lymphoma were analysed. All patients underwent gastric resection: total gastrectomy in 44%, subtotal in 34% and extended gastric resection in 22% of the patients. In 27% of the cases gastric resection was part of a multimodal therapy. While RO resection was achieved in 80% of the cases, the overall 5-year survival rate was 74%. In a multivariate analysis using the Cox model R0-resection independently improved prognosis, whereas extended gastric resection was associated with a poorer survival rate. As R0-resection should be the aim of every oncologic surgery, preoperative identification of the R0-resectable cases by extended patient evaluation is of great importance.
Melcher
G A
GA
Chirurgische Klinik und Poliklinik, Technischen Universität München.
Roder
J D
JD
Fink
U
U
Funk
A
A
Fellbaum
C
C
Busch
R
R
D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate
Das Non-Hodgkin-Lymphom des Magens, chirurgische Therapie und Prognose.